UCLOUDLINK GROUP INC (UCL) Fundamental Analysis & Valuation

NASDAQ:UCL • US90354D1046

Current stock price

1.41 USD
-0.07 (-4.73%)
Last:

This UCL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. UCL Profitability Analysis

1.1 Basic Checks

  • UCL had positive earnings in the past year.
  • UCL had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: UCL reported negative net income in multiple years.
  • In multiple years UCL reported negative operating cash flow during the last 5 years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • UCL's Return On Assets of 11.06% is amongst the best of the industry. UCL outperforms 100.00% of its industry peers.
  • With an excellent Return On Equity value of 24.79%, UCL belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
  • UCL has a Return On Invested Capital of 15.62%. This is amongst the best in the industry. UCL outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.06%
ROE 24.79%
ROIC 15.62%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

  • With a decent Profit Margin value of 9.23%, UCL is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • In the last couple of years the Profit Margin of UCL has grown nicely.
  • UCL's Operating Margin of 9.22% is in line compared to the rest of the industry. UCL outperforms 45.45% of its industry peers.
  • In the last couple of years the Operating Margin of UCL has declined.
  • UCL has a Gross Margin (49.77%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 9.22%
PM (TTM) 9.23%
GM 49.77%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. UCL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so UCL is creating value.
  • Compared to 1 year ago, UCL has more shares outstanding
  • UCL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, UCL has a worse debt to assets ratio.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • UCL has an Altman-Z score of -1.33. This is a bad value and indicates that UCL is not financially healthy and even has some risk of bankruptcy.
  • UCL has a worse Altman-Z score (-1.33) than 81.82% of its industry peers.
  • UCL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • UCL has a better Debt to Equity ratio (0.24) than 86.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -1.33
ROIC/WACC1.9
WACC8.23%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • UCL has a Current Ratio of 1.68. This is a normal value and indicates that UCL is financially healthy and should not expect problems in meeting its short term obligations.
  • UCL's Current ratio of 1.68 is amongst the best of the industry. UCL outperforms 90.91% of its industry peers.
  • A Quick Ratio of 1.55 indicates that UCL should not have too much problems paying its short term obligations.
  • UCL has a Quick ratio of 1.55. This is amongst the best in the industry. UCL outperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.55
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. UCL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.82% over the past year.
  • The Earnings Per Share has been growing slightly by 3.89% on average over the past years.
  • The Revenue has decreased by -2.48% in the past year.
  • Measured over the past years, UCL shows a very negative growth in Revenue. The Revenue has been decreasing by -10.37% on average per year.
EPS 1Y (TTM)81.82%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%166.67%
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-16.03%

3.2 Future

  • UCL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -55.59% yearly.
  • UCL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.19% yearly.
EPS Next Y51.5%
EPS Next 2Y-55.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.42%
Revenue Next 2Y-0.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

4

4. UCL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.05, which indicates a rather cheap valuation of UCL.
  • UCL's Price/Earnings ratio is rather cheap when compared to the industry. UCL is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, UCL is valued rather cheaply.
  • The Forward Price/Earnings Ratio is negative for UCL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 7.05
Fwd PE N/A
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.64
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as UCL's earnings are expected to decrease with -55.59% in the coming years.
PEG (NY)0.14
PEG (5Y)1.81
EPS Next 2Y-55.59%
EPS Next 3YN/A

0

5. UCL Dividend Analysis

5.1 Amount

  • UCL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

UCL Fundamentals: All Metrics, Ratios and Statistics

UCLOUDLINK GROUP INC

NASDAQ:UCL (3/20/2026, 8:26:22 PM)

1.41

-0.07 (-4.73%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)03-11
Earnings (Next)05-19
Inst Owners17.76%
Inst Owner Change-18.6%
Ins Owners9.48%
Ins Owner ChangeN/A
Market Cap53.06M
Revenue(TTM)85.24M
Net Income(TTM)7.87M
Analysts80
Price Target8.16 (478.72%)
Short Float %0.27%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)543.56%
Min EPS beat(2)-0.99%
Max EPS beat(2)1088.12%
EPS beat(4)2
Avg EPS beat(4)111.39%
Min EPS beat(4)-692.08%
Max EPS beat(4)1088.12%
EPS beat(8)5
Avg EPS beat(8)104.95%
EPS beat(12)8
Avg EPS beat(12)94.38%
EPS beat(16)8
Avg EPS beat(16)-21.18%
Revenue beat(2)0
Avg Revenue beat(2)-10.91%
Min Revenue beat(2)-16.59%
Max Revenue beat(2)-5.23%
Revenue beat(4)2
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-16.59%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-3.73%
Revenue beat(12)5
Avg Revenue beat(12)-2.95%
Revenue beat(16)7
Avg Revenue beat(16)-2.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)1000%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.46%
Valuation
Industry RankSector Rank
PE 7.05
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.7
EV/EBITDA -0.64
EPS(TTM)0.2
EY14.18%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.27
BVpS0.84
TBVpS0.83
PEG (NY)0.14
PEG (5Y)1.81
Graham Number1.95
Profitability
Industry RankSector Rank
ROA 11.06%
ROE 24.79%
ROCE 23.93%
ROIC 15.62%
ROICexc N/A
ROICexgc N/A
OM 9.22%
PM (TTM) 9.23%
GM 49.77%
FCFM N/A
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score3
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.55
Altman-Z -1.33
F-Score3
WACC8.23%
ROIC/WACC1.9
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.82%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%166.67%
EPS Next Y51.5%
EPS Next 2Y-55.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%-16.03%
Revenue Next Year-9.42%
Revenue Next 2Y-0.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y85.18%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-107.68%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y-107.68%
OCF growth 3YN/A
OCF growth 5Y9.78%

UCLOUDLINK GROUP INC / UCL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UCLOUDLINK GROUP INC (UCL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to UCL.


Can you provide the valuation status for UCLOUDLINK GROUP INC?

ChartMill assigns a valuation rating of 4 / 10 to UCLOUDLINK GROUP INC (UCL). This can be considered as Fairly Valued.


How profitable is UCLOUDLINK GROUP INC (UCL) stock?

UCLOUDLINK GROUP INC (UCL) has a profitability rating of 5 / 10.


How financially healthy is UCLOUDLINK GROUP INC?

The financial health rating of UCLOUDLINK GROUP INC (UCL) is 4 / 10.


What is the expected EPS growth for UCLOUDLINK GROUP INC (UCL) stock?

The Earnings per Share (EPS) of UCLOUDLINK GROUP INC (UCL) is expected to grow by 51.5% in the next year.